文献速递胸部PETCT

基于支持向量机的18F-FDG PET/CT影像预测非小细胞肺癌纵隔淋巴结转移

Prediction of mediastinal lymph node metastasis based on 18F-FDG PET/CT imaging using support vector machine in non-small cell lung cancer.
PubMed 文献 · Eur Radiol · 2020-11-17

研究纳入71例非小细胞肺癌患者的219枚淋巴结(37枚转移),基于7项淋巴结特征构建支持向量机模型,比较9种模型的AUC和准确率以选出最佳模型并简化为评分规则。最佳模型平均准确率80.09%(95%CI 70.27~89.19%),AUC 0.81;淋巴结标准化摄取值最大值与主动脉弓的比值在模型中起主要作用。简化评分规则:评分>3.0视为恶性,<1.5倾向良性,1.5~3.0怀疑转移。

要点

  • 评分>3.0的淋巴结视为恶性,<1.5倾向良性,1.5~3.0怀疑转移。
  • 淋巴结标准化摄取值最大值与主动脉弓的比值在支持向量机模型中起主要作用。
  • 最佳模型平均准确率80.09%(95%CI 70.27~89.19%),AUC 0.81。

核心结论

  • 基于18F-FDG PET/CT影像的支持向量机模型能够预测非小细胞肺癌患者的转移性淋巴结;简化后的评分方法可能部分帮助临床医生相对更容易地确定非小细胞肺癌患者的临床分期。

研究设计与样本

  • 研究纳入71例患者的219枚淋巴结(37枚转移),基于7项淋巴结特征构建支持向量机模型,比较9种模型的AUC和准确率以选出最佳模型。

诊断标准与关键数值

  • 最佳模型最大准确率91.89%(68/74,95%CI 83.11~96.54%),AUC 0.94。
  • 最佳模型最小准确率66.22%(49/74,95%CI 54.85~75.98%),AUC 0.66。
  • 最佳模型平均准确率80.09%(59,266/74,000,95%CI 70.27~89.19%),AUC 0.81。
  • 简化评分规则:评分>3.0的淋巴结视为恶性,<1.5倾向良性,1.5~3.0怀疑转移。

临床应用与阅片要点

  • 作者认为基于18F-FDG PET/CT特征的支持向量机模型可能帮助临床医生对非小细胞肺癌患者的转移性纵隔淋巴结做出决策。
  • 作者认为简化评分规则降低了模型复杂度,可能部分帮助临床医生相对更容易地确定非小细胞肺癌患者的临床分期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to develop a classification method based on support vector machine (SVM) to improve the diagnostic performance of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) to detect the lymph node (LN) metastasis in non-small cell lung cancer (NSCLC).

METHOD: Two hundred nineteen lymph nodes (37 metastatic) from 71 patients were evaluated in this study. SVM models were developed with 7 LN features. The area under the curve (AUC) and accuracy of 9 models were compared to select the best model. The best SVM model was simplified on the basis of the feature weights and value distribution to further suit the clinical application.

RESULTS: The maximum, minimum, and mean accuracy of the best model was 91.89% (68/74, 95% CI 83.11~96.54%), 66.22% (49/74, 95% CI 54.85~75.98%), and 80.09% (59,266/74,000, 95% CI 70.27~89.19%), respectively, with an AUC of 0.94, 0.66, and 0.81, respectively. The best SVM model was finally simplified into a score rule: LNs with scores more than 3.0 were considered as malignant ones, whereas LNs with scores less than 1.5 tended to be benign ones. For the LNs with scores within a range of 1.5-3.0, metastasis was suspected.

CONCLUSION: An SVM model based on 18F-FDG PET/CT images was able to predict the metastatic LNs for patients with NSCLC. The ratio of the maximum of standard uptake value of LNs to aortic arch played a major role in the model. After simplification, the model could be transferred into a scoring method which may partly help clinicians determine the clinical staging of patients with NSCLC relatively easier.

KEY POINTS: • The SVM model based on 18F-FDG PET/CT features may help clinicians to make a decision for metastatic mediastinal lymph nodes in patients with NSCLC. • The SURblood plays a major role in the SVM model. • The score rule based on the SVM model simplified the complexity of the model and may partly help clinicians determine the clinical staging of patients with NSCLC relatively easier.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yin G, Song Y, Li X, et al. Prediction of mediastinal lymph node metastasis based on 18F-FDG PET/CT imaging using support vector machine in non-small cell lung cancer. Eur Radiol. 2020. PMID: 33201286. doi:10.1007/s00330-020-07466-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。